SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 200.79-0.2%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (28957)6/24/1999 3:01:00 PM
From: Mudcat  Read Replies (1) of 32384
 
<I think that you are confusing the oral Targretin filing with the topical Panretin approval(which was expected in 1998). A filing of Targretin in 1999 has been the deadline for quite some time now. Last fall, it wasn't even clear if oral or topical Targretin would be filed first>

I am 90% sure I read the planned date for a Targretin NDA was 4Q98 from something that Ligand had put out(News release or annual report). I will look around to see if I can find it and let you know. In the meantime, I guess the following historical posts on this thread may have to justify my claim. Look at posts 24145, 26598, 25741, and 26672. I guess there is a slight possibility that I could have gotten the 4Q98 date from one of these posts. Henry I'm sure you will want to verify that these posters are creditable. LOL
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext